autoimmune disease

Roche's Genentech spends $15M to rocket into GenEdit’s NanoGalaxy
Fierce Biotech
Tue, 01/23/24 - 10:43 am
Roche
Genentech
GenEdit
drug development
gene therapy
autoimmune disease
CRISPR eyes autoimmune disease in revamp of cell therapy plans
BioPharma Dive
Tue, 12/5/23 - 11:38 am
CRISPR Therapeutics
cell therapy
autoimmune disease
cancer
Amgen-backed Seismic shakes up $121M financing for preclinical immunology programs
Fierce Biotech
Mon, 12/4/23 - 10:17 am
Seismic Therapeutic
Amgen Ventures
funding
autoimmune disease
Biogen nabs FDA nod for biosimilar version of Roche's blockbuster Actemra
Fierce Pharma
Mon, 10/2/23 - 11:48 am
Biogen
Roche
Actemra
autoimmune disease
biosimilars
Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function
Benzinga
Thu, 09/21/23 - 11:55 am
Inmagene
Aditum Bio
Celexor
autoimmune disease
inflammatory disease
Hutchmed eyes Chinese approval for autoimmune disorder drug after phase 3 success
Fierce Biotech
Mon, 08/21/23 - 10:36 am
Hutchmed
sovleplenib
China
clinical trials
autoimmune disease
Cartesian maps the path for an autoimmune disease cell therapy
EP Vantage
Fri, 06/23/23 - 09:41 am
Cartesian Therapeutics
MRNA
CAR-T
autoimmune disease
Lilly makes fresh bet on IL-17 with $2.4B acquisition of Dice Therapeutics
Fierce Biotech
Tue, 06/20/23 - 11:31 am
Eli Lilly
M&A
DiCE Therapeutics
autoimmune disease
Attovia, a new California biotech, launches with plans to rethink how drugs bind their targets
BioPharma Dive
Tue, 06/20/23 - 11:26 am
Attovia Therapeutics
cancer
autoimmune disease
Immunovant Shares Touch 52-Week High After FDA Green Lights IMVT-1402 Study
Marketwatch
Tue, 05/23/23 - 10:12 am
Immunovant
immunology
IMVT-1402
autoimmune disease
FDA
Here come the PD-1 agonists
EP Vantage
Tue, 05/23/23 - 09:49 am
PD-1 agonists
autoimmune disease
Eli Lilly
rheumatoid arthritis
peresolimab
Magenta agrees to reverse merger with Dianthus after setbacks
BioPharma Dive
Wed, 05/3/23 - 10:48 pm
Magenta Therapeutics
M&A
Dianthus Therapeutics
autoimmune disease
Joe Jimenez's Aditum finds fresh twist on old idea, paying $10M for autoimmune BTK inhibitor
Fierce Biotech
Fri, 04/28/23 - 10:00 am
venture capital
Joe Jimenez
Aditum Bio
autoimmune disease
Regeneron bets on ‘Treg’ cell therapy with Sonoma deal
BioPharma Dive
Tue, 03/28/23 - 10:26 am
Regeneron
Sonoma Biotherapeutics
autoimmune disease
cell therapy
Treg cell therapy
Merck KGaA, spying a major market, pays Aqilion €10M to tackle tough autoimmune target
Fierce Biotech
Thu, 02/16/23 - 10:26 am
Merck KGaA
Aqilion
autoimmune disease
Ex-Shire drug improves outcomes in autoimmune disease, setting Certa on path to phase 3
Fierce Biotech
Mon, 02/6/23 - 10:29 am
Certa Therapeutics
Shire
FT011
autoimmune disease
clinical trials
scleroderma
Amgen extends autoimmune pact with small Michigan biotech
Endpoints
Wed, 01/18/23 - 11:02 pm
Amgen
autoimmune disease
Evoq Therapeutics
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline
BioSpace
Tue, 12/6/22 - 10:42 am
AbbVie
HotSpot Therapeutics
drug discovery
drug development
autoimmune disease
Zenas zips up $118M to launch phase 3 for rare autoimmune disease candidate
Fierce Biotech
Tue, 11/8/22 - 10:22 pm
Zenas BioPharma
Xencor
funding
autoimmune disease
Pfizer tops pharma reputation rankings from autoimmune patients
Medical Marketing and Media
Mon, 11/7/22 - 05:21 pm
Pfizer
autoimmune disease
reputation

Pages